Evaluation of Glycine-Bearing Celecoxib Derivatives as a Colon-Specific Mutual Prodrug Acting on Nuclear Factor-ΚB, an Anti-Inflammatory Target

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s88543
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Nuclear Factor Kappa B in Liver Disease

Gut
Gastroenterology
1999English

The Attraction of Chemokines as a Target for Specific Anti-Inflammatory Therapy

British Journal of Pharmacology
Pharmacology
2009English

Inflammatory Cytokines and Nuclear Factor-Kappa B Activation in Adolescents With Bipolar and Major Depressive Disorders

Psychiatry Research
PsychiatryMental HealthBiological Psychiatry
2016English

A Colon-Specific Prodrug of Metoclopramide Ameliorates Colitis in an Experimental Rat Model

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Effects of Polyphenol-Rich Plant Products on the Nuclear Factor-Kappa B Pathway

Istanbul Bilim University Florence Nightingale Journal of Medicine
2019English

Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy

Frontiers in Oncology
Cancer ResearchOncology
2013English

Role of Nuclear Factor-Kappa B in Feline Injection Site Sarcoma

BMC Veterinary Research
MedicineVeterinary
2019English

Staphylococcal Panton-Valentine Leukocidin Induces Pro-Inflammatory Cytokine Production and Nuclear Factor-Kappa B Activation in Neutrophils

PLoS ONE
Multidisciplinary
2012English

Asbestos Induces Nuclear Factor Kappa B (NF-kappa B) DNA-binding Activity and NF-kappa B-Dependent Gene Expression in Tracheal Epithelial Cells.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy